{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:15:17Z","timestamp":1788257717622,"version":"build-2803163510"},"reference-count":16,"publisher":"Scientific Scholar","content-domain":{"domain":["ijmr.org.in"],"crossmark-restriction":true},"short-container-title":["Indian J Med Res"],"abstract":"<jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>Carbapenem-resistant gram-negative pathogens are associated with limited treatment options and poor clinical outcomes. This study assessed the prevalence, distribution, antimicrobial susceptibility, and clinical outcomes of multidrug-resistant organisms from intensive care units and related wards in a South Indian tertiary care hospital over three years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A retrospective laboratory-based study was conducted between October 2022 to May 2025, analysed culture-positive specimens from the selected locations using hospital information system data. Multidrug-resistant organisms were defined according to international criteria. Organisms included carbapenem-resistant\n                      <jats:italic>Enterobacterales<\/jats:italic>\n                      , carbapenem-resistant\n                      <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                      , carbapenem-resistant\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      , methicillin-resistant\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      , vancomycin-resistant\n                      <jats:italic>Enterococcus<\/jats:italic>\n                      spp., and trimethoprim\u2013sulfamethoxazole resistant\n                      <jats:italic>Stenotrophomonas maltophilia.<\/jats:italic>\n                      Demographics, specimen distribution, antimicrobial susceptibility, and outcomes were analysed using descriptive and inferential statistics.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 8,704 specimens processed, 3,450 (39.6%) were culture-positive and 750 (34.2%) were multidrug-resistant. Carbapenem-resistant\n                      <jats:italic>Enterobacterales<\/jats:italic>\n                      accounted for (n=490,65.3%) of multidrug-resistant organisms, followed by carbapenem-resistant\n                      <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                      (n=85,11.3%), carbapenem-resistant\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      (n=85,11.3%), methicillin-resistant\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      (n=40,5.3%), vancomycin-resistant\n                      <jats:italic>Enterococcus<\/jats:italic>\n                      spp. (n=34,4.5%), and trimethoprim\u2013sulfamethoxazole-resistant\n                      <jats:italic>S. maltophilia<\/jats:italic>\n                      (n=16,2.1%).\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      predominated among carbapenem-resistant\n                      <jats:italic>Enterobacterales<\/jats:italic>\n                      isolates. Multidrug-resistant organisms were significantly more common in intensive care units (539\/750,71.9%) and among patients aged &gt;60 y (399\/750,53.2%) (\n                      <jats:italic>P<\/jats:italic>\n                      &lt;0.05).\n                      <jats:italic>Enterobacterales<\/jats:italic>\n                      showed high resistance to cephalosporins and fluoroquinolones, while\n                      <jats:italic>A. baumannii<\/jats:italic>\n                      demonstrated limited meropenem susceptibility (18\/110,16.3%). Overall mortality among patients with multidrug-resistant infections was (191\/750,25.5%), with 94% (180\/191) of deaths clinically attributed to infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation and conclusions<\/jats:title>\n                    <jats:p>\n                      Carbapenem-resistant\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      and\n                      <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                      are the predominant multidrug-resistant organisms, especially in intensive care units. These highlights the urgent need for strengthened antimicrobial stewardship, infection-control practices and ongoing antimicrobial resistance surveillance.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.25259\/ijmr_103_2026","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:09:07Z","timestamp":1787998147000},"page":"445-452","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Carbapenem-resistant and other multidrug-resistant organisms in a South Indian tertiary care centre: A laboratory-based study"],"prefix":"10.25259","volume":"164","author":[{"given":"Arya S.","family":"Kumar","sequence":"first","affiliation":[{"name":"Department of Infection Control & Epidemiology, Amrita Institute of Medical Sciences & Research Centre, Kochi, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev K.","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Medical Administration, Amrita Institute of Medical Sciences, Faridabad, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera Susan","family":"John","sequence":"additional","affiliation":[{"name":"Department of Infection Control & Epidemiology, Amrita Institute of Medical Sciences & Research Centre, Kochi, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"H.","sequence":"additional","affiliation":[{"name":"Department of Infection Control & Epidemiology, Amrita Institute of Medical Sciences & Research Centre, Kochi, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimi","family":"Mohan","sequence":"additional","affiliation":[{"name":"Department of Medical Administration, Amrita Institute of Medical Sciences & Research Centre, Kochi, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irine Anna","family":"Sebastain","sequence":"additional","affiliation":[{"name":"Department of Infection Control & Epidemiology, Amrita Institute of Medical Sciences & Research Centre, Kochi, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishnavi","family":"S.","sequence":"additional","affiliation":[{"name":"Department of Infection Control & Epidemiology, Amrita Institute of Medical Sciences & Research Centre, Kochi, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"10.25259\/IJMR_103_2026\/ref-1","doi-asserted-by":"publisher","first-page":"404","DOI":"10.52403\/ijrr.20210550","article-title":"Microbiological profile of significant multi-drug resistant organisms isolated in a tertiary care centre, Kerala, India","volume":"8","author":"Kaniyarakkal","year":"2021","journal-title":"Int J Res Rev."},{"key":"10.25259\/IJMR_103_2026\/ref-2","doi-asserted-by":"publisher","first-page":"107125","DOI":"10.1016\/j.ijantimicag.2024.107125","article-title":"Dramatic increase in antimicrobial resistance in ESKAPE clinical isolates over the 2010\u20132020 decade in India","volume":"63","author":"Kharat","year":"2024","journal-title":"Int J Antimicrob Agents."},{"key":"10.25259\/IJMR_103_2026\/ref-3","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/cid\/ciy955","article-title":"The mortality burden of multidrug-resistant pathogens in India: A retrospective, observational study","volume":"69","author":"Gandra","year":"2019","journal-title":"Clin Infect Dis."},{"key":"10.25259\/IJMR_103_2026\/ref-4","doi-asserted-by":"publisher","first-page":"286","DOI":"10.4103\/0976-9668.116970","article-title":"Antimicrobial resistance in India: A review","volume":"4","author":"Kumar","year":"2013","journal-title":"J Nat Sci Biol Med."},{"key":"10.25259\/IJMR_103_2026\/ref-5","first-page":"18","article-title":"Antibiotic resistance: experience in a tertiary care hospital in South India","volume":"58","author":"Subbalaxmi","year":"2010","journal-title":"J Assoc Physicians India."},{"key":"10.25259\/IJMR_103_2026\/ref-6","doi-asserted-by":"publisher","first-page":"1571231","DOI":"10.3389\/fmed.2025.1571231","article-title":"Prevalence and molecular insights into carbapenem resistance: A 2-year retrospective analysis of superbugs in South India","volume":"12","author":"Lathakumari","year":"2025","journal-title":"Front Med (Lausanne)."},{"key":"10.25259\/IJMR_103_2026\/ref-7","doi-asserted-by":"publisher","first-page":"107184","DOI":"10.5493\/wjem.v15.i3.107184","article-title":"Burden of multi-drug-resistant organisms in a tertiary healthcare institute in North India: Implications for regional public health","volume":"15","author":"Singh","year":"2025","journal-title":"World J Exp Med."},{"key":"10.25259\/IJMR_103_2026\/ref-10","doi-asserted-by":"publisher","first-page":"4065603","DOI":"10.1155\/2016\/4065603","article-title":"Multidrug resistant and extensively drug resistant bacteria: A study","volume":"2016","author":"Basak","year":"2016","journal-title":"J Pathog."},{"key":"10.25259\/IJMR_103_2026\/ref-11","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.22207\/jpam.17.4.21","article-title":"Prevalence of carbapenem-resistant Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa in a tertiary care hospital in Eastern India: A pilot study","volume":"17","author":"Verma","year":"2023","journal-title":"J Pure Appl Microbiol."},{"key":"10.25259\/IJMR_103_2026\/ref-12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/QCO.0000000000000622","article-title":"Carbapenem use in critically ill patients","volume":"33","author":"Patrier","year":"2020","journal-title":"Curr Opin Infect Dis."},{"key":"10.25259\/IJMR_103_2026\/ref-13","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3390\/antibiotics14111136","article-title":"Diagnostic stewardship trends and antimicrobial resistance profiles of bacteria isolated in Zambia: A five-year retrospective study (2020\u20132024)","volume":"14","author":"Chizimu","year":"2025","journal-title":"Antibiotics (Basel)."},{"key":"10.25259\/IJMR_103_2026\/ref-14","doi-asserted-by":"publisher","first-page":"462","DOI":"10.33590\/emj\/10300425","article-title":"Prevalence of carbapenem-resistant enterobacteriaceae and the genes responsible for carbapenemase production in a tertiary care hospital in South India","volume":"12","author":"Joshi","year":"2023","journal-title":"European Medical Journal."},{"key":"10.25259\/IJMR_103_2026\/ref-15","doi-asserted-by":"publisher","first-page":"358","DOI":"10.5530\/jyp.2018.10.79","article-title":"Prevalence of antimicrobial resistant pathogens in severe sepsis and septic shock patients","volume":"10","author":"Babu","year":"2018","journal-title":"Journal of Young Pharmacists."},{"key":"10.25259\/IJMR_103_2026\/ref-16","first-page":"467","article-title":"Study of prevalence and antimicrobial susceptibility pattern of organisms isolated from ICU patients","volume":"13","author":"Chaudhari","year":"2023","journal-title":"Natl J Physiol Pharm Pharmacol."},{"key":"10.25259\/IJMR_103_2026\/ref-17","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.2147\/IDR.S403360","article-title":"Prevalence and trends of carbapenem-resistant Pseudomonas aeruginosa and acinetobacter species at the Ethiopian public health institute","volume":"16","author":"Abdeta","year":"2023","journal-title":"Infect Drug Resist."},{"key":"10.25259\/IJMR_103_2026\/ref-18","doi-asserted-by":"publisher","first-page":"e440","DOI":"10.5001\/omj.2022.22","article-title":"Prevalence of methicillin-resistant staphylococcus aureus in India: A systematic review and meta-analysis","volume":"37","author":"Patil","year":"2022","journal-title":"Oman Med J."}],"container-title":["The Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ijmr.org.in\/carbapenem-resistant-and-other-multidrug-resistant-organisms-in-a-south-indian-tertiary-care-centre-a-laboratory-based-study\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/ijmr.org.in\/carbapenem-resistant-and-other-multidrug-resistant-organisms-in-a-south-indian-tertiary-care-centre-a-laboratory-based-study\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:34:54Z","timestamp":1788255294000},"score":1,"resource":{"primary":{"URL":"http:\/\/ijmr.org.in\/carbapenem-resistant-and-other-multidrug-resistant-organisms-in-a-south-indian-tertiary-care-centre-a-laboratory-based-study\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":16,"alternative-id":["10.25259\/IJMR_103_2026"],"URL":"https:\/\/doi.org\/10.25259\/ijmr_103_2026","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"article-number":"445"}}